Literature DB >> 10774625

Interactions between drugs and Asian medicine: displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicines Chan Su and Lu-Shen-Wan.

P Datta1, A Dasgupta.   

Abstract

Asian medicines are widely used as alternative medicine. However, interactions between drugs and Asian medicines have been poorly studied. Chan Su and Lu-Shen-Wan are Asian medicines that contain the cardiaoactive compound bufalin. Bufalin is structurally similar to digitoxin and is also strongly bound to serum albumin. The authors studied possible displacement of digitoxin from the protein binding site by bufalin. The authors prepared three serum pools from patients taking digitoxin and supplemented aliquots of each serum pool with no bufalin (control) and 25 ng/mL, 50 ng/mL, 100 ng/mL, 250 ng/mL, 500 ng/mL, and 1000 ng/mL bufalin. The authors observed significant displacement of digitoxin by bufalin as evidenced by increased free digitoxin concentrations. For example, the concentration of free digitoxin increased from a control value of 1.6 ng/mL to 2.5 ng/mL in the presence of 1000 ng/mL bufalin (total digitoxin: 36.3 ng/mL) in the serum pool 1. The authors observed similar increases in free digitoxin concentrations in other serum pools in the presence of various concentrations of bufalin. The authors used a chemiluminescent assay and ACS:180 analyzer to measure both total (in the original serum) and free (in the protein-free ultrafiltrate) digitoxin concentrations because the chemiluminescent assay does not cross-react with bufalin. When an acetone/water (1:1 by volume) extract of Chan Su was added to a serum pool containing digitoxin, the authors observed a significantly increased free digitoxin concentration, indicating that Chan Su can displace digitoxin from the protein binding site in vitro. The authors conclude that bufalin and acetone/water extract of Chan Su can cause significant displacement of digitoxin from the protein binding site.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10774625     DOI: 10.1097/00007691-200004000-00002

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  3 in total

1.  Drug-herb interactions: unexpected suppression of free Danshen concentrations by salicylate.

Authors:  Deepali Gupta; Mehri Jalali; Alice Wells; Amitava Dasgupta
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Triggering apoptotic death of human malignant melanoma a375.s2 cells by bufalin: involvement of caspase cascade-dependent and independent mitochondrial signaling pathways.

Authors:  Yu-Ping Hsiao; Chun-Shu Yu; Chien-Chih Yu; Jai-Sing Yang; Jo-Hua Chiang; Chi-Cheng Lu; Hui-Ying Huang; Nou-Ying Tang; Jen-Hung Yang; An-Cheng Huang; Jing-Gung Chung
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-07       Impact factor: 2.629

Review 3.  New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin.

Authors:  Chien-Shan Cheng; Jiaqiang Wang; Jie Chen; Kuei Ting Kuo; Jian Tang; Huifeng Gao; Lianyu Chen; Zhen Chen; Zhiqiang Meng
Journal:  Cancer Cell Int       Date:  2019-04-11       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.